Skip to main content

. 1990 Feb 24;300(6723):483–484. doi: 10.1136/bmj.300.6723.483

Dangers of thrombolysis.

PMCID: PMC1662328 PMID: 2107922

483

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Burrell C. J., Skehan J. D., Cowley M. L., Barrett C. W., Mills P. G. Districts' use of thrombolytic agents. BMJ. 1990 Jan 27;300(6719):237–238. doi: 10.1136/bmj.300.6719.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
Jalihal S., Morris G. K. Antistreptokinase titres after intravenous streptokinase. Lancet. 1990 Jan 27;335(8683):184–185. doi: 10.1016/0140-6736(90)90276-b. [DOI] [PubMed] [Google Scholar]
Stafford P. J., Strachan C. J., Vincent R., Chamberlain D. A. Multiple microemboli after disintegration of clot during thrombolysis for acute myocardial infarction. BMJ. 1989 Nov 25;299(6711):1310–1312. doi: 10.1136/bmj.299.6711.1310. [DOI] [PMC free article] [PubMed] [Google Scholar]
White H. D., Norris R. M., Brown M. A., Takayama M., Maslowski A., Bass N. M., Ormiston J. A., Whitlock T. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med. 1987 Oct 1;317(14):850–855. doi: 10.1056/NEJM198710013171402. [DOI] [PubMed] [Google Scholar]
Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES